International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis ( efinition of patients at risk of VTE an...)

HOME >> MEDICINE >> TECHNOLOGY

International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis

efinition of patients at risk of VTE and prophylaxis recommendations provided by the of Chest Physicians (ACCP) evidence-based consensus guidelines (3). The study included two categories of hospitalized patients: patients in medical wards 40 years of age or older, and patients in surgical wards, 18 years or older.

Doctor Fred Anderson, Director of the Center for Outcomes Research at the University of Massachusetts Medical School who conducted the study commented "ENDORSE is the first study to provide a global view of VTE risk and prophylaxis practices throughout the world. With more than 60,000 patients studied in more than 30 countries, the scope of ENDORSE is unprecedented. In view of the quality of the data collected and a common method to assess patients at risk for VTE and prophylaxis used, this study gives us a unique picture both globally and locally about the extent of the hospitalized patient population at risk for VTE and how these patients are managed."

ENDORSE demonstrates the high prevalence of patients at risk for VTE: 52% of hospitalized patients surveyed were at risk for VTE, corresponding to 64% of surgical patients and 42% of medical patients. The prevalence of patients at risk was consistent across the countries surveyed, demonstrating the importance of VTE risk on a global scale.

Importantly, when considering the use of recommended prophylaxis in hospitals, only 50% of hospitalized patients at risk for VTE received a method of prophylaxis recommended by the ACCP, corresponding to 59% of surgical and 40% of medical patients at risk for VTE. The use of recommended prophylaxis varied across countries; however, it was globally sub-optimal and even more so in medical than surgical patients, as the majority of medical patients at risk for VTE (60%) did not receive recommended prophylaxis.

As highlighted by Doctor Victor Tapson, Co-chair of the ENDORSE Steering Committee: "ENDORSE clearly shows that VTE is a critical safety i
'"/>

Page: 1 2 3 4
Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
6. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
8. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
11. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop

Post Your Comments:

(Date:3/17/2010)... Fourteenth Annual New York Emerging Growth Institutional Investor Forum at The Grand Hyatt in New York City on Tuesday, March 23, 2010 . , ... , , ... ... ...

(Date:3/17/2010)... Access MediQuip, LLC, the nation,s first and largest provider of outsourced implantable medical device management ... "RMS," for its customers nationwide. The new release is designed to protect patients, inform and ... ... ...

(Date:3/17/2010)... based on the,following elements: ,, ... , , ... ... "As former Vice-President for clinical drug development with a ...

Breaking Medicine Technology:Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum 2 Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices 2 Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices 3 Infinitus Clinical Research Consolidates - Sino-Indian CRO Enhances Core Capabilities 2 Infinitus Clinical Research Consolidates - Sino-Indian CRO Enhances Core Capabilities 3 Infinitus Clinical Research Consolidates - Sino-Indian CRO Enhances Core Capabilities 4 American Laser Centers Names Health Care Veteran Steven Straus CEO 59137 1 American Laser Centers Names Health Care Veteran Steven Straus CEO 59137 2 Deloitte Recap Launches New Series of Biopharmaceutical Business Intelligence Tools 14396 1 Deloitte Recap Launches New Series of Biopharmaceutical Business Intelligence Tools 14396 2 Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 1 Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference 5333 2

[0] Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum [0] Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices [0] Infinitus Clinical Research Consolidates - Sino-Indian CRO Enhances Core Capabilities

... the 90th annual Endocrine Society meeting show,significant improvements among women ... ... ANN ARBOR, Mich, June 16 QuatRx Pharmaceuticals today,announced detailed ... Ophena(TM) (ospemifene tablets) to treat postmenopausal women with,symptoms of vulvovaginal ...

... Results Presented at Endocrine Society 90th Annual Meeting ... 16 ,Bionovo Inc. (Nasdaq: BNVI ) today ... its drug candidate, MF101. The data were presented ... that, in neurons,differentiated from mouse stem cells and ...

Other Medicine Technology:Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 2 Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 3 Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy 4 Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation 2 Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation 3

Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy Bionovo's Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation

(Date:3/18/2010)... ... patients. The Plastic Surgery Institute of Southeast Texas provides their patients with a more suitable ... Houston, ... procedures. It is also one of the top concerns for people considering plastic surgery. TIVA, ...

(Date:3/18/2010)... , ... , ... ... WASHINGTON , March 18 Kids in Michigan will take center stage in the fight against tobacco on ...

(Date:3/18/2010)... Prevention Initiatives , ... , ... ... WASHINGTON , March 18 Kids in New Hampshire will take center stage in the ...

(Date:3/18/2010)... Initiatives , ... , ... ... WASHINGTON , March 18 Kids in Nebraska will take center stage in the fight against ...

(Date:3/18/2010)... March 18 A tasty, wholesome ... moms and kids can happily agree on. Simply…Go-Gurt is made ... of artificial colors, flavors and sweeteners. It is filled with ... milk containing both calcium and vitamin D. These convenient portable ...

[0] Plastic Surgery Institute of Southeast Texas Offers Milder Anesthesia for Outpatient Procedures [0] Michigan Kids 'Kick Butts' on March 24 [0] New Hampshire Kids 'Kick Butts' on March 24 [0] Nebraska Kids 'Kick Butts' on March 24 [0] New Simply...Go-Gurt Contains No High Fructose Corn Syrup, Artificial Flavors or Colors

... by 50%, study concludes, , , MONDAY, April 7 ... offer nutrition education and reward students for nutritious ... preventing childhood obesity, according to a Temple University ... multifaceted nutrition program reduced the number of overweight ...

... science education, scientific research, and the role science should play in ... ... NEW YORK, April 7, 2008 Since its launch in October,2006, the ... human health issues facing the 21st century, including the,brain, the human genome, ...

... Schizophrenia is a complex type of psychotic mental ... Huge gains in the effective treatment of individuals with ... of the first generation of antipsychotic drugs. The medications ... illness (delusions and hallucinations) and, to a lesser extent, ...

... SCRANTON, Pa., April 7, 2008 Penn Foster ... build essential skills,for working professionals. The program offerings ... -- Anatomy and Physiology, This broad ... working adults in,the health professions. Prospective nurses, medical ...

... is high in the antioxidant EGCG (epigallocatechin-3- gallate) which ... prematurely aged. Studies have suggested that the combination of ... providing protection against certain types of cancers, including breast ... University of Mississippi researchers now finds that consuming EGCG ...

... Enjoy His Young Family,and Active Life, MIDDLE ISLAND, ... Trade Center on September 11, 2001, New York,City Patrolman ... Now,more than seven years later, O,Connor needs help overcoming ... later in,the line of duty., At 32, Mr. ...

Other Medicine News:Health News:School Environment Can Curb Kids' Weight Gain 2 Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 2 Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 3 Health News:Treatment with an anti-psychotic drug found to cause changes in metabolism earlier than expected 2 Health News:Treatment with an anti-psychotic drug found to cause changes in metabolism earlier than expected 3 Health News:Penn Foster Career School Offers Certificate Programs 2 Health News:Ingredient found in green tea significantly inhibits breast cancer growth in female mice 2 Health News:The SCOOTER Store Donates Power Scooter to Former NYPD Officer Who Responded to 9/11 2 Health News:The SCOOTER Store Donates Power Scooter to Former NYPD Officer Who Responded to 9/11 3

School Environment Can Curb Kids' Weight Gain Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science'Treatment with an anti-psychotic drug found to cause changes in metabolism earlier than expected Penn Foster Career School Offers Certificate Programs Ingredient found in green tea significantly inhibits breast cancer growth in female mice The SCOOTER Store Donates Power Scooter to Former NYPD Officer Who Responded to 9/11

... hip retractor system provides ... total hip replacement. Fully ... surgeon techniques on any ... Hand-held retractors can easily ...

... every general surgery need. No matter the ... GO550/GO500 Omni-Flex General Retractor Systems give you ... way possible., ,With large and small frame ... the GO550 provides comprehensive flexibility and completely ...

... The Arx Ceramic Spinal ... biocompatible implants based on ... that offers physicians and ... other synthetic and allograft ...

... QC 253 is an assayed quality ... of total hemoglobin and hemoglobin fractions on ... those needing a control that parallels the ... COHb. QC 253 is available in three ...

Medicine Products:

Omni-Flex Hip Retractor System GO550/GO500 Omni-Flex™ General Retractor Systems Arx™ Ceramic Spinal Spacer System™QC 253 Full Range CO-Oximeter Control

( efinition of patients at risk of VTE an...)International ENDORSE Study Shows That the Majority of Hospitalized,Patients Surveyed are at Risk for VTE and Many do not Receive,Recommended VTE prophylaxis,Health